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Abstract
In transmissible spongiform encephalopathies (TSEs), a group of fatal neurodegenerative disorders affecting many species,
the key event in disease pathogenesis is the accumulation of an abnormal conformational isoform (PrP
Sc) of the host-
encoded cellular prion protein (PrP
C). While the precise mechanism of the PrP
C to PrP
Sc conversion is not understood, it is
clear that host PrP
C expression is a prerequisite for effective infectious prion propagation. Although there have been many
studies on TSEs in mammalian species, little is known about TSE pathogenesis in fish. Here we show that while gilthead sea
bream (Sparus aurata) orally challenged with brain homogenates prepared either from a BSE infected cow or from scrapie
infected sheep developed no clinical prion disease, the brains of TSE-fed fish sampled two years after challenge did show
signs of neurodegeneration and accumulation of deposits that reacted positively with antibodies raised against sea bream
PrP. The control groups, fed with brains from uninfected animals, showed no such signs. Remarkably, the deposits
developed much more rapidly and extensively in fish inoculated with BSE-infected material than in the ones challenged
with the scrapie-infected brain homogenate, with numerous deposits being proteinase K-resistant. These plaque-like
aggregates exhibited congophilia and birefringence in polarized light, consistent with an amyloid-like component. The
neurodegeneration and abnormal deposition in the brains of fish challenged with prion, especially BSE, raises concerns
about the potential risk to public health. As fish aquaculture is an economically important industry providing high protein
nutrition for humans and other mammalian species, the prospect of farmed fish being contaminated with infectious
mammalian PrP
Sc, or of a prion disease developing in farmed fish is alarming and requires further evaluation.
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Introduction
Transmissible spongiform encephalopathies or prion diseases
are a group of fatal neurodegenerative disorders, including
Creutzfeldt-Jakob disease (CJD), Fatal Familial Insomnia (FFI)
and Gerstmann-Stra ¨ussler-Scheinker disease (GSS) in humans,
scrapie in sheep and goats and bovine spongiform encephalopathy
(BSE) in cattle [1].
The transmission of clinical prion diseases is limited by the so-
called ‘‘species barrier’’ to conversion of endogenous host prion
protein (PrP
C) to its abnormal, partially proteinase K-resistant
conformational isoform, PrP
Sc. When high enough, this ‘‘barrier’’
can greatly impair or prevent potential interspecies transmissions,
even under optimal conditions of dose and infection route.
However, evidence of TSE replication without accompanying
symptoms of clinical disease has prompted debate on the existence
of asymptomatic infected individuals in an exposed population
[2,3].
The identification of apparent PrP orthologues in lower
vertebrates, including fish [4–16], raises the question of their
susceptibility to prion diseases. While fish PrP-like sequences do
not share high homology with their mammalian relatives (Table
S1), they do contain several strongly conserved prion protein
structural motifs [17]. Although mammalian to fish TSE
transmission is considered unlikely [18], it is not certain that the
species barrier would be high enough to prevent TSE transmission
to fish.
The BSE epidemic has been linked to TSE-infected cattle feed
[19] and the recognition of BSE in domestic cattle inevitably
raised concerns about the potential risk to other ruminant and
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risk-reducing measures include a total EU-wide ban on the use of
all processed animal protein in livestock and aquaculture feeds.
Any consideration of lifting this ban requires a scientific assessment
of the TSE transmission risk through fishmeal. Another issue to be
addressed is the rising concern that pigs, poultry or fish bred for
human consumption and inadvertently fed with TSE-contaminat-
ed feed could eventually either develop clinical TSE or serve as
reservoirs of infectivity without ever displaying clinical disease
themselves. Such an assessment should consider the risk from
TSE-contaminated feed being fed to farmed fish [18,21]. In
aquaculture, a rapidly growing industry of economic importance
in several EU countries, the farmed fish receive commercial feed
containing 40–55% protein during the 12–20 months they
generally spend in aquaculture facilities. Although remote, the
possibility that some of this feed might be contaminated with
mammalian prion cannot be excluded.
In the present work, we evaluated the potential transmission of
TSEs to gilthead sea bream, a commercially important fish species.
After force-feeding with multiple doses of brain homogenate
prepared from either healthy or naturally BSE- or scrapie-infected
cow or sheep, the fish were monitored for 2 years for evidence of
disease development by clinical, histopathological and immuno-
histochemical criteria. None of the fish examined, showed
symptoms of clinical disease. However, signs of neurodegeneration
were often present and abnormal deposition was detected in the
brains of both the scrapie-challenged and the BSE-challenged fish
by 24 months post inoculation.
Results and Discussion
To evaluate the clinical state of the fish, we monitored control
and TSE–challenged populations on a daily basis. Since locomotor
deficits are often a major feature of the clinical presentation of
prion diseases in a variety of hosts, we used the swimming behavior
of the challenged fish as an indicator of their general activity and
exploratory behavior. No clinical symptoms, including erratic
swimming or behavioral abnormalities, were observed in any of
the groups monitored. Although unusual in prion disease, a similar
absence of clinical symptoms upon interspecies challenge has been
reported for both the first passage of sheep scrapie and hamster
prion transmission to mice [2]. In these cases, subsequent passage
of brain material from the challenged individuals to additional
mice did produce clinical disease, thereby demonstrating that
asymptomatic animals can harbour high levels of infectious prions
in their brains. Additionally, it is important to note that while
certain experimentally or virally induced neurodegenerative effects
do modify swimming parameters in fish, such as the swimming
distance and orientation, the mean velocity, the turning angle and
the equilibrium [22–24], this is not always the case. For instance,
while both sea bass and sea bream can be infected with nodavirus,
a naturally occurring piscine virus that causes brain lesions in both
species, sea bream, in contrast to sea bass, show no clinical
symptoms of disease [25,26].
To facilitate our evaluation we generated polyclonal antibodies
against four different fish PrPs. The specificity of each antiserum
was confirmed by both western blot (Fig. S1A) and immunohis-
tochemistry (IHC) (Fig. S2A–C) with normal sea bream brain.
Furthermore, anti-mammalian PrP antibodies (6H4, 12F10) did
not stain sea bream brain, nor did our anti-fish PrP antisera
recognize mammalian PrP
Sc (Fig. S1B). Moreover, absorption of
our SaurPrP1 (Sparus aurata PrP1) antisera with recombinant sea
bream PrP-1 protein [6], against which it was raised, resulted in a
complete loss of its specific immunostaining in control fish (Fig.
S2D).
Initially, in order to determine the distribution of normal
endogenous PrP in the central nervous system of gilthead sea
bream, we used our polyclonal antisera to perform a detailed
immunohistochemical evaluation on brain sections from control
fish. Regions displaying abundant PrP included the optic tectum
(Fig. 1A), valvula cerebelli (Fig. 1B) and corpus cerebelli (Fig. 1C),
while strong PrP-immunopositivity was generally observed in the
nerve fibers (Fig. 1D). The most prominently stained regions of the
optic tectum, homologue to the superior colliculus in mammals
[22], were striatum fibrosum marginale (Fig. 1A and Fig. S2A, B)
and striatum fibrosum profundum (Fig. S2A, B). Less intense
labeling was observed in the striatum griseum centrale and
striatum plexiform fibrosum externum layers of the optic tectum
(Fig. 1A and Fig. S2A, B). Cerebellar PrP-immunopositivity was
detected mainly in the molecular layer, between Purkinje cell
dendrites, and in the granular layer, in the matrix surrounding the
granule cells (Fig. 1C). The valvula cerebelli, a rostral protrusion of
the cerebellum in the midbrain ventricle that has no counterpart in
mammals, showed significant PrP-immunopositivity, similar to
that observed in the molecular and granular layers of cerebellum
(Fig. 1B and Fig. S2A, B). In cerebral regions, including thalamus,
medulla oblongata, diencephalon and the lateral telencephalic
pallium, proposed to be a homologue of the mammalian
hippocampus [22], we observed intense labeling of fiber bundles
(Fig. 1D), consisting primarily of dendritic and axonal prolonga-
tions in the neuropil. The same general PrP
C expression pattern
was observed in challenged and control populations, with no
variation detected over time. The remarkable similarity of the
overall immunolabeling pattern obtained with our SaurPrP1
antiserum in sea bream brain to the PrP-immunostaining profile in
the mammalian brain [27,28] provided further assurance of the
specificity of our antibody for piscine PrP.
At the intracellular level, staining outlining the neuronal body
was present in most of the neuronal populations observed, e.g. in
the large neurons of the brainstem (Figure 1E). Axons displayed
intense staining, while diffuse staining was observed inside some of
these neuronal somata, suggesting a degree of PrP-immunoposi-
tivity within cell departments, e.g. the Golgi complex (Fig. 1E).
These findings suggest that the intracellular localization of PrP in
fish brain is comparable to the neuronal intracellular localization
of mammalian PrP [27,29].
To test for pathology in selected peripheral tissues, we examined
intestines and spleens from TSE-challenged fish, sampled at
different timepoints. No lesions or any other abnormalities were
revealed in comparison to the control individuals. Intestinal PrP-
immunoreactivity was evident in the serosa, myenteric plexus and
submucous plexus (Fig. 1F). At all timepoints, PrP-immunolabel-
ing in spleen and intestinal tissue was similar in both TSE-
challenged and control fish and revealed no PK-resistance and no
lesions or any other abnormalities.
Detailed examination of brain sections revealed no histopath-
ological evidence of disease in scrapie–challenged sea bream
through 18 months post inoculation (p.i.). At 24 months, however,
2 out of 5 fish showed limited abnormal, PrP-immunoreactive,
PK-sensitive, extracellular deposits (Table S3B) in the neuropil of
brainstem, diencephalon, corpus cerebelli, valvula cerebelli, optic
tectum and telencephalon (Fig. 2). Whilst the number of animals
where plaques were found was too small to reach statistical
significance, based on the high likelihood that the fish examined
developed no plaques, we believe that the observation of
aggregates in 2 out of 5 fish at the final time point could be
considered as an important event of qualitative (and not
TSE Transmission to Sea Bream
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control fish force-fed normal sheep brain homogenate (Fig. S3 and
Table S3B).
Plaque-like deposits were also observed in the brains of the BSE-
challenged fish, beginning at earlier timepoints. Initially, at 8
months p.i., the majority of these aggregates were localized in
brainstem, less in diencephalon and optic tectum, and even fewer
in valvula cerebelli, cerebellum and telencephalon (Figure 3D–F).
Just 10% of the deposits were PK-resistant and these had a mean
diameter of 5 mm. Subsequently, we observed a general
progression in their distribution, size, PK-resistance and morpho-
logical features. The incidence of the abnormal deposition was
higher in fish sacrificed at earlier time points than at intermediate
time points. However, the highest levels were measured at later
time points, evocative of the phenomenon described in other prion
cross-species transmission studies as an ‘‘eclipse’’ period [30].
Further analysis of the spatial and temporal progression
revealed that with increasing time p.i., the deposition became
more prominent in rostral brain regions, although caudal regions
continued to be affected. By 24 months p.i., deposition in the
brains of the BSE-challenged sea bream presented a striking
picture, in which three out of five fish showed 500–800 deposits
each, 70–85% of which were PK-resistant with a mean diameter
of 30 mm. With regard to the remaining two fish, one displayed
approximately 150 deposits, 93% of which were PK-resistant and
the other showed only limited signs of abnormal aggregation.
While deposits continued to be distributed throughout the brain at
24 months p.i., in the three highly affected fish the greatest
increases in deposit numbers occurred in brainstem and
diencephalon. The progression of the abnormal deposition is
apparent in Fig. 3. and summarized in Figs. 4 and 5 and Tables
S3A and S4.
In contrast to the BSE-challenged fish, no aggregates were
detected at any time in the brains of the control fish fed with
normal bovine brain homogenate (Fig. S4 and Table S3A).
Notably, none of the brain tissues positive for abnormal deposition
showed evidence of neuronal body degeneration. Finally, no
residual mammalian PrP
Sc was detected using 12F10 and 6H4
Figure 1. Normal PrP
C distribution in CNS and peripheral tissues. Sagittal, 4 mm-thick brain and intestine sections from control fish were
treated with SaurPrP1 (1:2000 and 1:250, respectively) and normal endogenous PrP labeling in different anatomical regions was examined. A, Optic
tectum; B, Valvula cerebelli; C, Corpus cerebelli; D, Nerve fibers in diencephalon; E, Neurons in brainstem; F, PrP-immunoreactive areas in the
intestine. Rectangles indicate areas of magnification shown in the panel directly below. Arrowheads show positively stained regions. SGC, striatum
griseum centrale; SPFE, striatum plexiforme et fibrosum externum; SFM, striatum fibrosum marginale; ML, molecular layer; GL, granular layer, m,
plasma membrane; a, axon; c, cytoplasm. se, serosa; mp, myenteric plexus; sp, submucous plexus. Scale bars, 100 mm.
doi:10.1371/journal.pone.0006175.g001
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suggest that while both TSE strains resulted in similar abnormal
brain pathology, the brains of BSE-challenged individuals were
more rapidly and severely affected than those of scrapie-
challenged fish. BSE, known to be a zoonotic TSE, may represent
a thermodynamically favored PrP
Sc conformation that is permis-
sive for PrP expressed in a wide range of mammalian species [31].
Despite this permissibility, however, attempts to orally transmit
BSE to pigs and chickens have failed [32,33].
To characterize the nature of the deposition, we employed a
variety of conventional staining techniques. Congo red-stained
deposits in BSE-challenged sea bream brains at 24 months p.i.
were congophilic (Figs. 6A and 7B) and birefringent under
polarized light (Fig. 6B), suggesting an amyloid or amyloid-like
component [34]. No Congo red birefringence was observed in
either the control tissues or the scrapie-challenged fish brains (data
not shown). While the plaque-like aggregates were prominent with
hematoxyline and eosin (H&E) (Fig. 7A), Klu ¨ver-Barrera staining
for myelin structures and von Kossa staining for calcium
deposition both gave negative reactions (data not shown). Deposits
were also PAS positive (Fig. 7C) but Alcian blue negative (Fig. 7E),
indicating the presence of carbohydrates and the absence of acidic
glycosaminoglycans, respectively. Finally, our four anti-fish PrP
antisera positively labeled the deposits (see Fig. 7D for SaurPrP1),
whereas the 12F10 and 6H4 antibodies did not (data not shown).
Two main types of plaque-like deposits were identified in the
brains of the BSE-challenged fish: fibrous, diffusely stained
aggregates (Fig. 8A, D, G, J), and those that were more amorphous
and dense (Fig. 8B, E, H, K). At 8 months, small aggregates,
generally in close proximity to neurofibrils, were detected, whereas
the majority of the adjacent fiber bundles remained intact
(Fig. 3D–F). At 10 and 12 months the first signs of neurodegen-
eration appeared as a primitive disorganization of dendrites and
axons. By 16 and 18 months, the distention of neurites, mostly in
grey matter, was exacerbated. The extensive deconstruction of
microfilaments within the axons and the loss of their coherence,
especially at 18 months, were detected histopathologically.
Aggregates of dystrophic neurites were immunostained with
SaurPrP1, exhibiting a diffuse PrP-immunolabeling with some
marginal spicule-like projections (data not shown). At 24 months
the diffusely immunolabeled aggregates of dystrophic neurites
(Fig. 8A, D, G, J) coexisted with deposits that appeared more
amorphous, condensed and flocculated and therefore were more
intensely stained with all the techniques used (Fig. 8B, E, H, K).
Figure 2. Progression of abnormal deposition in 2 scrapie-challenged fish. Sagittal brain sections from scrapie-challenged fish at 12 and 24
months p.i. were stained with H&E (A, D), or treated with SaurPrP1 (1:2000) without PK-digestion (B, E) and with PK-digestion (C, F). Images show
diencephalon. The mean number of deposits (per section of fish containing deposits) observed in different brain regions without PK-treatment is
indicated by the fill-type in the schematic drawings at the far left. CCe, corpus cerebelli; Di, diencephalon; Hyp, hypothalamus; LI, lobi inferioris; MO,
medulla oblongata; OB, olfactory bulb; OC, optic chiasm; OlN, olfactory nerve; OT, optic tectum; P, pituitary; POA, preoptic area; SC, spinal cord; Tel,
telencephalon; TL, torus longitudinalis; VCe, valvula cerebelli. The following areas were not examined: OB; OIN; OC; P. Rectangles indicate areas of
magnification shown in the panels directly below. Arrowheads indicate the abnormal aggregates. Scale bars, 100 mm.
doi:10.1371/journal.pone.0006175.g002
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tion with time, it is tempting to hypothesize a scenario, in which
the first type of aggregates (Fig. 8A, D, G, J) could have been the
developmental ancestor of the second (Fig. 8B, E, H, K) and in
which each may illustrate different stages of pathogenesis. The
distention of axons and dendrites observed at 10 and 12 months
p.i. reflects an initial neurodegenerative process in the brains of the
BSE-challenged fish that may have been a very early reaction
following exposure to the infectious agent. The complete
destruction of the protective outer neurite layers, including the
myelin sheath, followed by the disorganization of the microfila-
ments and microtubuli could have subsequently created the first
morphological type of aggregates initially detected at 16 and 18
months. These ‘‘pre-mature’’ deposits mainly consist of dystrophic
Figure 3. Progression of abnormal deposition in BSE-challenged fish. Sagittal brain sections from BSE-challenged fish taken at the indicated
times p.i. were stained with H&E (A, D, G), or immunolabeled with SaurPrP1 (1:2000) without PK-digestion (B, E, H) and with PK-digestion (C, F, I).
Images show diencephalon. The mean number of deposits (per section of fish containing deposits) observed in different brain regions without PK-
treatment is indicated by the fill-type in the schematic drawings at the far left. Abbreviations as in Figure 2. The following areas were not examined:
OB; OIN; OC; P. Rectangles indicate areas of magnification shown in the panels directly below. Arrowheads indicate the abnormal aggregates. Scale
bars, 100 mm.
doi:10.1371/journal.pone.0006175.g003
TSE Transmission to Sea Bream
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tions, at their periphery (Fig. 8A, D, G, J). Given that aggregates
were partially PK-resistant and showed affinity for Congo red by
24 months, the next step in the progression may have been the
complete deconstruction of the fibers leading to the creation of a
homogenous, flocculated, extracellular material that we describe
as ‘‘mature’’ deposits (Fig. 8B, E, H, K), with increased PrP-
immunopositivity, PK-resistance, congophilia and birefringence in
polarized light [35]. Fish brains at 24 months post inoculation
exhibit both types of abnormal aggregates, including intermediate
Figure 4. Abnormal deposits in the brains of the BSE- and the scrapie-challenged fish with reference to time. Each dot corresponds to
the number of aggregates observed per brain section in each individual before PK-treatment (A, D) and after PK digestion (B, E), or to the
percentage of PK-resistant aggregates in each BSE-challenged fish (C). Bars indicate the means and the standard error means (SEMs).
doi:10.1371/journal.pone.0006175.g004
TSE Transmission to Sea Bream
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the previously described morphological categories.
The classical neuropathological hallmarks of prion diseases
include neurodegeneration, spongiform change and gliosis, while
PrP
Sc deposition is observed in the majority of TSEs. The lesion
profile in the brains of the BSE-challenged fish shares both
similarities and differences in comparison to this histological and
immunohistochemical pattern of mammalian prion diseases.
Specifically, the distribution of abnormal aggregates within the
brains of 4 BSE-challenged fish at 24 months p.i. shared certain
similarities with the PrP
Sc deposition pattern observed in TSE-
affected mammalian brain. Notably, the abnormal deposits in sea
bream brain were only detected in regions where neuronal
parenchyma was present, a feature greatly resembling the location
of mammalian prion deposition [36]. Cerebellum was extensively
affected, with large fibrous aggregates in the molecular layer and a
granule-like deposition profile in the granular layer, a pattern
similar to that observed in mammalian TSEs [37]. The abnormal
deposition in sea bream brain was also prominent both in the
lateral nucleus of the ventral telencephalic area, a fish counterpart
to the basal nucleus of Meynert in mammals [38], and the lateral
telencephalic pallium, homologue to the mammalian hippocam-
pus [22]. Both thalamus and diencephalon displayed numerous
aggregates, most of which were interspersed within neuronal
fibers. In striking contrast to the general neuropathological profile
of mammalian TSEs, however, no vacuoles were observed in any
regions of the fish brains examined. While spongiosis is a main
characteristic in most prion diseases, it must be noted that in
certain TSE subtypes there is little or no spongiform change. Such
has been the case in patients suffering from FFI, an inherited
human prion disease [39].
Evidence of neurodegeneration, although distinct from that
commonly associated with mammalian prion disease, was
apparent in many brain regions, primarily in places where the
abnormal deposition was located adjacent to or within complexes
of neurites (Fig. 8C, L). It is important to note, however, that no
degeneration associated with neuronal somata was detected in any
of the anatomical regions examined. The absence of classically
defined neurodegeneration might be related to the ability of fish to
produce new neurons continuously throughout their lifetime. It is
known, for instance, that adult fish can regenerate damaged retinal
tissue, optic axons and descending brainstem axons, leading to
functional recovery [40,41]. In fact, this ability of adult fish for
CNS regeneration has been postulated to explain the asymptom-
atic carrier state of halibut persistently infected with nodavirus
Figure 5. Progressive increase in the size of proteinase K
resistant deposits in BSE-challenged fish. The mean diameter of
the immunohistochemically detected (SaurPrP1) deposits after protein-
ase K–digestion is given with reference to time p.i..
doi:10.1371/journal.pone.0006175.g005
Figure 6. Congo red staining of deposits in the brain of BSE-challenged sea bream. A sagittal, 10 mm-brain section from a BSE-challenged
individual, 24 months p.i., was stained with Congo red. A, Diencephalon with light microscopy; B, Same region in polarized light. Rectangles indicate
areas of magnification shown in the panel directly below. Arrowheads indicate the abnormal aggregates. Scale bars, 100 mm.
doi:10.1371/journal.pone.0006175.g006
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6175Figure 7. Staining of an aggregate in the brain of a BSE-challenged fish 24 months p.i. with different techniques. A, H&E; B, Congo red
in normal light; C, PAS; D, IHC (SaurPrP1) after PK-digestion; E, Alcian blue. Rectangles in the left panel indicate areas of magnification shown in the
right panel. Scale bars, 100 mm (left panel) or 10 mm (right panel).
doi:10.1371/journal.pone.0006175.g007
TSE Transmission to Sea Bream
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like’’ temporal appearance of the abnormal deposition, as well as
to the lack of clinical symptoms in our BSE-challenged fish.
Despite the positive IHC results, western blotting failed to detect
PK-resistant PrP isoforms in the TSE-challenged fish brains (Fig.
S5), possibly because the whole brain homogenates used did not
have a high enough concentration of PK-resistant PrP to allow
detection. In fact, it is clear from the IHC results that even at 24
months p.i., the brain regions associated with the abnormal
deposits constitute only a small percentage of the whole brain
mass.
The results of this TSE transmission study with gilthead sea
bream indicate the development of a CNS histopathology in the
brains of the fish challenged with the TSE-inocula. This
neuropathology displays characteristics resembling a novel fish
amyloidosis more than a classical TSE. Specifically, while the fish
Figure 8. Morphology of the abnormal deposition in the brains of the BSE-challenged fish 24 months p.i.. Sagittal 4 mm-thick brain
sections where stained with hematoxylin without a counterstain. pH variation renders the deposits visible by light microscopy. The panels on the left
show diffuse ‘‘pre-mature’’ deposits in A, diencephalon; D, optic tectum; G, cerebellum; J, brainstem. The middle panels display examples of
compact ‘‘mature’’ deposition in B, diencephalon; E, optic tectum; H, cerebellum; K, telencephalon. The panels at the right show intermediate stage-
abnormal deposition within fiber bundles that disrupts synapses in C, diencephalon; F, optic tectum; I, valvula cerebelli; L, telencephalon. S, spicule-
like projections; CM, condensed material. Scale bars, 10 mm.
doi:10.1371/journal.pone.0006175.g008
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abnormalities, we did find numerous plaque-like deposits in the
brains of a significant proportion of the BSE-challenged fish,
especially. Although much of the PrP associated with these
deposits is PK-sensitive, this should not be taken as an indicator of
low potential infectivity, as instances of clinical prion disease, and
even infectivity, associated with extremely low levels of detectable
PK-resistant PrP have been reported [43–45].
In light of the serious ramifications that would follow an
unequivocal demonstration of prion disease transmission to fish, it
must be emphasized here that the abnormal deposition we
observed in the brains of the TSE-challenged fish could possibly
have resulted from pathogenic factors other than the prions they
were fed. Despite the fact that no such naturally occurring, cross-
species infections from mammals to fish have ever been reported
[46], we cannot completely rule out this possibility. Thus, however
unlikely, one must consider the possibility that the brains used to
prepare the inocula for the TSE challenge were infected with an
undetected virus or bacteria in addition to the scrapie or BSE
present. Together, the time course of brain lesion appearance, i.e.
months not days, the ability of the agent to survive the oral
challenge route, the absence of brain histopathology in any of the
control groups and the production of novel histological lesions in
both the BSE- and the scrapie-challenged fish, in the absence of
inflammation, however, make this possibility a remote one. A
more plausible alternate explanation would be that the amyloido-
genic nature of the TSE-inocula might have contributed to the
development of a novel fish brain amyloidosis.
Infectivity and transmissibility are crucial issues that still need to
be addressed. From a public health standpoint, the transmissibility
of each prion strain and the relative ease with which it crosses
species barriers, are its most significant characteristics. The
spectrum of prionopathies, which has broadened in recent years,
includes prion diseases that are not readily transmissible (e.g. some
GSS cases), prion strains often associated with negligible clinical
symptoms (e.g. the Nor98 scrapie strain), and even some without
detectable PrP
Sc (e.g. PSPr) [44,47,48]. It is clear, then, that the
evaluation and identification of both unusual prion diseases and
prion diseases affecting unusual hosts is a complex task, requiring
lengthy studies of pathogenesis, infectivity and transmissibility
[49]. Until ongoing transmission studies using ‘‘bovinized’’
transgenic mice are completed, the possibility that the affected
sea bream brain tissue might be infectious, must be taken seriously
in any consideration to lift EU feed bans, especially those related
to farmed fish.
Materials and Methods
Ethics Statement
All fish used in the experiments described in this work were
treated in accordance with EU Council Directive 86/609/EEC
for the protection of animals used for experimental and other
scientific purposes.
Fish
Sixteen hundred gilthead sea bream of approximately 20 g
weight were purchased from a commercial farm (Interfish,
Greece). At the commercial farm, before purchase, fish were fed
commercial pellets (Biomar), none of which contained protein
sources derived from land animal products. After transportation to
the laboratory (Fisheries Research Institute, Kavala, Greece), they
were maintained at 18uC in temperature-controlled recirculating
water tanks. After a two week adaptation period, the fish were
divided into groups of 200 in separate tanks. The fish were allowed
a further three weeks of acclimatization before experimental
manipulations were initiated.
Preparation of inocula
For the force feeding of the fish, 10% (w/v) brain homogenates
from scrapie-infected sheep, healthy control sheep, BSE-infected
cow and healthy control cow were prepared in PBS (pH 7.4). For
the sheep brain homogenates both cerebellum and brainstem from
two animals were used (kindly provided by Dr. P. Toumazos,
Veterinary Services, Cypriot Ministry of Agriculture), while the
bovine brain homogenates were each prepared from the brainstem
of a single animal. The BSE sample (RBSE 21028), taken in 1991
from a female Fresian two months after disease onset, was kindly
provided by Dr. Ian Dexter, Pathology Department, Veterinary
Laboratories Agency, Weybridge, UK. As healthy herdmate tissue
was not available, the healthy control bovine brainstem was taken
from a local Greek cow in 2002. All brain samples were stored at
280uC prior to use.
Challenge and maintenance
For inoculations, fish were removed from the tanks and mildly
anaesthetized with 0.3% ethylene glycol monophenyl ether.
Following anaesthesia, each fish was force-fed 100 ml brain
homogenate. In total, 2 groups of 400 fish each, were each
treated with scrapie-infected or control sheep brain homogenate
and 2 groups of 200 fish each were each treated with BSE-infected
or control bovine brain homogenate. For both the experimental
and control groups, the force-feeding procedure was repeated
fortnightly for a total of five treatments, so that the cumulative
inoculum for each fish was 50 mg brain equivalents. Following the
inoculation period all fish were kept on a maintenance diet with
commercially available chow to prevent excessive growth and
overcrowding during the multiyear study period. Data regarding
maintenance of the fish, mortality due to technical and natural
causes and sampling are shown in Table S2.
Clinical examination
Clinical evaluation of the fish in each tank was made on a daily
basis, checking especially for any behavioral or swimming
abnormalities.
Histopathological evaluation
Individuals from each group (5 TSE-treated and 5 controls)
were sacrificed at regular selected time points post inoculation (3,
6, 8, 10, 12, 14, 16, 18, 24 months) and tissue samples, including
brain, spleen and intestine, were taken. Tissues were fixed in
buffered formalin (pH 7.4), embedded in paraffin wax and finally
4 mm-thick serial sections were subjected to conventional staining
with a variety of staining techniques including H&E, PAS, Alcian
blue, von Kossa and Klu ¨ver-Barrera. The resulting sections were
examined histologically using light microscopy (Axioplan 2
Imaging System, Zeiss). Tissue pictures were taken using the
Nikon Digital Sight DS-SMc visualizing system.
Congo red staining
For the identification of possible amyloid-like structures, 10 mm-
thick brain sections were deparaffinized, stained with 0.5% Congo
red (Merck, Darmstadt, Germany) alcohol solution for 15 minutes,
destained in 0.2% KOH, subsequently counterstained with
Mayer’s hematoxyline, and after a short dehydration, they were
finally cleared in xylene. The stained sections were observed
microscopically under both normal and polarized light (Axiolab
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sator Lambda, +/25u,6 625).
Generation of polyclonal antisera
The presumed mature sequences spanning residues 24–580 of
zebrafish (Danio rerio) PrP-1 and residues 18–539 of zebrafish PrP-2
(sequence data provided by Dr. Edward Ma ´laga-Trillo, Depart-
ment of Biology, University of Konstanz), were each amplified
from genomic DNA, whereas the mature sequence of gilthead sea
bream (Sparus aurata) PrP-1 spanning residues 26–475 was cloned
from plasmid DNA. All three were cloned into the pET21d DNA
vector (Novagen, San Diego, CA) to produce recombinant
proteins tagged with six histidine residues at the C-terminus.
After sequence verification by double-stranded sequencing, the
recombinant proteins were expressed in BL21 (DE3) E.coli
(Stratagene, La Jolla, CA) with IPTG induction from single clone
colonies. The recombinant proteins were purified under denatur-
ing conditions from cell lysates on Ni-NTA agarose columns
(Qiagen, Hilden, Germany) and then specifically eluted with
imidazole. The polyclonal antisera ZebPrP1, ZebPrP2 and
SaurPrP1 were raised against the purified zebrafish PrP-1,
zebrafish PrP-2 and sea bream PrP-1 proteins respectively, by 3
successive subcutaneous inoculations of rabbits with 150 to 200 mg
of recombinant protein at 4 weeks intervals. All pertinent sequence
data are deposited in GenBank and the accession numbers are
given at the end of the manuscript.
Affinity purification of SaurPrP1 polyclonal antiserum
2 aliquots containing 150 mg of gilthead sea bream recombinant
PrP-1 protein each, were loaded onto 10% polyacrylamide gels
and after SDS-PAGE, they were each electrotransferred to a
nitrocellulose or a PVDF membrane. After electrophoresis the two
membranes were stained with amido black staining solution (0.1%)
and the protein-containing membrane pieces were finally excised.
After a blocking step in 50 mM Tris HCl [pH 7.4], 150 mM
NaCl, 0.05% Tween 20 (TBST) containing 5% milk, for 1 hr at
RT, each membrane piece was probed with blocking buffer
containing 500 ml of SaurPrP1 antiserum, at 4uC overnight.
Following several washes, the IgGs that specifically bound to PrP-
1, were finally eluted from the membranes with 0.2 M
Glycine.HCl [pH 2.5], for 5 min at 4uC. Each eluate was
neutralized with 2 M Tris HCl [pH 9.0], and then dialyzed
overnight at 4uC in 50 mM Tris HCl [pH 7.4], 150 mM NaCl
(TBS), using 100 mm-Spectra/Por molecularporous membrane
tubing (Spectrum Medical Industries, Los Angeles, USA).
Following dialysis, the purified IgGs were saturated in buffer
containing 20 mM Tris HCl [pH 8.4], 150 mM NaCl, 5 mM
EDTA, 1% gelatin, 0.1% BSA.
Depletion of recombinant gilthead sea bream PrP-1 –
specific immunoglobulin fraction from SaurPrP1
polyclonal antiserum
SaurPrP1 polyclonal antibody was diluted in phosphate
buffered saline (1:2000), containing 5% normal goat serum,
2.5% BSA and 0.05% Tween 20. The antibody was incubated
with 0.6 mM of recombinant gilthead sea bream PrP-1 protein at
4uC overnight. The depleted antiserum was briefly centrifuged
before use in all negative immunohistochemistry control experi-
ments.
Immunohistochemistry
Four different polyclonal anti-PrP antibodies were used for the
immunohistochemical detection of the endogenous PrP proteins of
sea bream, namely ZebPrP1 (1:1000), ZebPrP2 (1:1000), SaurPrP1
(1:2000) and FuguPrP1 (1:500), the latter being raised by our
group against PrP-1 protein of Takifugu rubripes. The commercially
available monoclonal antibody, 12F10 (Cayman Chemical, Ann
Arbor, MI), raised against amino acids 142–160 of human PrP,
was used for the detection of residual mammalian PrP (1:200),
since it also displays cross-reactivity with both ovine and bovine
PrP. All paraffin sections were cut at 4 mm thickness. Depending
on the prion protein of interest, PrP
C or PrP
Sc, two different
pretreatment protocols were used. For PrP
C labeling, an antigen
retrieval step was performed by boiling in citrate-buffered saline
[pH 6.0] for 7 minutes before the staining procedure. For PrP
Sc
detection, the sections were hydrated-autoclaved at 121uC for 30
minutes, then incubated for 5 minutes in 90% formic acid prior to
an 8 minutes-incubation with proteinase K (Dako, Glostrup,
Denmark) at RT. Sections were treated with appropriate
biotinylated secondary antibodies (Vector Laboratories, Burlin-
game, CA) and visualized using the avidin-biotin method-based
Vectastain Elite ABC and the Diaminobezidine substrate kits
(Vector Laboratories, Burlingame, CA) according to the manu-
facturer’s instructions. Negative controls for immunohistochemis-
try involved omitting the primary antibody. Staining with
polyclonal (anti 14-3-3b, Santa Cruz, California, USA) and
monoclonal antibodies (12F10, 6H4) raised against proteins of
mammalian origin was also performed. The mouse anti-tubulin
monoclonal antibody (Abcam, Cambridge, UK) and the mono-
clonal SAF84 antibody (raised against SAF preparation from
infected hamster brain, assumed epitope 126–164) were used as
well.
PrP
Sc enrichment and Western blot analysis
Western blot analysis of potentially enriched mammalian and
teleost PrP
Sc was performed on brain homogenates from BSE-
infected cows, scrapie-infected sheep, and TSE-challenged fish.
Briefly, aliquots of 10% (w/v) brain homogenate were digested for
1h ra t3 7 uC with proteinase K at 25 mg/ml for sheep, 30 mg/ml
for cow and 0.1–10 mg/ml for sea bream. PMSF (5 mM) was
added to stop the protease digestion and PrP
Sc was precipitated
with NaCl (10%) (w/v). The pellet was washed with 25 mM Tris
HCl [pH 8.8] containing 0.05% sarkosyl and then resuspended in
an appropriate volume of 2.56 O’Farrell buffer for gel
electrophoresis.
For western blot analysis, untreated and proteinase K treated
brain homogenates were analyzed by SDS-PAGE on 12%
polyacrylamide gels and the separated proteins were then
transferred onto PVDF membranes. After blocking with phos-
phate buffered saline containing 0.1% Tween 20 (PBST) and 5%
milk, the immunoblots were probed with the fish-PrP specific
polyclonal antisera, ZebPrP1 (1:10000), ZebPrP2 (1:35000),
SaurPrP1 (1:20000), FuguPrP1 (1:20000), and the monoclonal
antibody 6H4 (1:5000) (Prionics, Zurich, Switzerland) overnight at
4uC. After washing, they were incubated for 1 hr with either
alkaline-phosphatase or horseradish-peroxidase conjugated sec-
ondary goat anti-rabbit or anti-mouse antibodies (Pierce, Rock-
ford, IL) diluted 1:10000 in PBST. The blots were developed using
the CDP-Star chemiluminescent substrate (NE Biolabs, Beverly,
MA), or the ECL Western blotting Substrate (Pierce, Rockford,
IL), depending on the secondary antibody and according to the
manufacturer’s instructions.
GenBank Accession Numbers
Danio rerio prion protein 1 coding sequuence: AY438683
Danio rerio prion protein 1: AAS00159
Danio rerio prion protein 2 coding sequence: AY438684
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Sparus aurata prion protein 1 coding sequence: ABB90540
Supporting Information
Table S1 Percentage amino acid sequence homology between
prion proteins of different species. Full sequences were aligned.
The NCBI accession numbers of sequence data are: Homo sapien
(human), AAC78725; Bos Taurus (cow), AAD19998; Ovis aries
(sheep), CAE00188; Mus musculus (mouse), AAH06703; Meso-
cricetus auratus (hamster), AAA37092; Takifugu rubripes (fugu),
AAN38988; Danio rerio (zebrafish) prion protein 1, AAS00159;
Danio rerio prion protein 2, AAS00160; Sparus aurata (gilthead
sea bream) prion protein 1, ABB90540. Sequence alignments were
performed by ALIGN (version 2, Myers and Miller, CABIOS
(1989) 4:11–17).
Found at: doi:10.1371/journal.pone.0006175.s001 (0.09 MB TIF)
Table S2 Cumulative record of the number of fish maintained
post challenge. A, Fish inoculated with either scrapie- or normal
ovine brain homogenate. B, Fish inoculated with either BSE- or
normal bovine brain homogenate.
Found at: doi:10.1371/journal.pone.0006175.s002 (0.04 MB
DOC)
Table S3 Cumulative record of brain tissue samples examined.
A, BSE-challenged and bovine control fish samples. B, Srapie-
challenged and ovine control fish samples.
Found at: doi:10.1371/journal.pone.0006175.s003 (0.14 MB
DOC)
Table S4 Cytoanatomical analysis of brains from BSE-chal-
lenged fish sacrificed 24 months post challenge. The deposits have
been classified into 2 morphological categories. F, fibrillary,
.10 mm in diameter; NF, non fibrillary, circular,10 mmi n
diameter. Plus and minus symbols indicate the abundance of
deposits: 2,0 ;+, 1–5; ++, 6–15; +++, 16–50, ++++, .50. NP,
anatomical region not present in section; Mol L, molecular layer;
Gran L, granular layer; WM, white matter; Cx, cortex; Ce,
cerebellum; Vc, valvula cerebelli; Tel, telencephalon; Di, dien-
cephalon; OT, optic tectum; Br. st., brain stem.
Found at: doi:10.1371/journal.pone.0006175.s004 (0.13 MB TIF)
Figure S1 Comparison of antibody specificities for the PrPs of
gilthead sea bream, cow and sheep by western blot analysis. A,
Five 0.4 mg brain equivalent-aliquots of gilthead sea bream brain
homogenate were loaded onto a 12% SDS-PAGE gel. B,
Alternating lanes of a 12% SDS-PAGE gel were loaded with
3 mg tissue equivalents of PrPSc-enriched (see Materials and
Methods) bovine BSE brain homogenate (lanes 1, 3, 5, 7 & 9) and
ovine scrapie brain homogenate (lanes 2, 4, 6, 8 & 10). The
electrophoretically separated proteins were transferred to PVDF
membranes that were cut into four sections (in B, each section
included two adjacent lanes). Each section was stained with one of
five primary antibodies: 6H4 (1:5000; lanes A1, B1, B2); FuguPrP1
(1:20000; lanes A2, B3, B4); ZebPrP1 (1:10000; lanes A3, B5, B6);
ZebPrP2 (1:35000; lanes A4, B7, B8); SaurPrP1 (1:20000; lanes
A5, B9, B10). After incubation with the appropriate alkaline-
phosphatase-conjugated secondary antibody, the blots were
developed with the CDP-Star reagent. The arrow heads indicate
the positions of the molecular mass markers: A, 62 kDa and
47.5 kDa; B, 32.5 kDa.
Found at: doi:10.1371/journal.pone.0006175.s005 (0.28 MB TIF)
Figure S2 Antibody specificity in IHC. Sagittal, 4 mm-thick
serial brain sections from control gilthead sea bream were treated
immunohistochemically with four different primary antibodies,
without proteinase K digestion. A, SaurPrP1 (1:2000); B, ZebPrP2
(1:2000); C, Pre-immune serum from the rabbit in which
SaurPrP1 was raised (1:2000); D, PrP-specific immunoglobulin-
depleted SaurPrP1 (1:2000). Arrowheads indicate the existence (A,
B) or absence (C, D) of PrP-immunopositivity. SGP, striatum
griseum periventriculare; SFP, striatum fibrosum profundum;
SGC, striatum griseum centrale; SPFE, striatum plexiforme et
fibrosum externum; SFM, striatum fibrosum marginale; ML,
molecular layer of the valvula cerebelli; GL, granular layer of the
valvula cerebelli. Scale bars, 100 mm.
Found at: doi:10.1371/journal.pone.0006175.s006 (8.23 MB TIF)
Figure S3 Temporal observation of the brains from control fish
challenged with normal ovine brain homogenate. Sagittal brain
sections taken at 12 and 24 months p.i. from fish challenged with
normal ovine brain homogenate were stained with H&E (A, D), or
immunolabeled with SaurPrP1 (1:2000) without PK-digestion (B,
E) and with PK-digestion (C, F). Images show diencephalon. The
mean number of deposits (per section of fish containing deposits)
observed in different brain regions without PK-treatment is
indicated by the fill-type in the schematic drawings at the far
left. Abbreviations as in Figure 2 of the main manuscript. The
following areas were not examined: OB; OIN; OC; P. Rectangles
indicate areas of magnification shown in the panels directly below.
Scale bars, 100 mm.
Found at: doi:10.1371/journal.pone.0006175.s007 (3.00 MB TIF)
Figure S4 Temporal observation of the brains from control fish
challenged with normal bovine brain homogenate. Sagittal brain
sections taken at the indicated timepoints p.i. from fish challenged
with normal bovine brain homogenate were stained with H&E (A,
D, G), or immunolabeled with SaurPrP1 (1:2000) without PK-
digestion (B, E, H) and with PK-digestion (C, F, I). Images show
diencephalon. The mean number of deposits (per section of fish
containing deposits) observed in different brain regions without
PK-treatment is indicated by the fill-type in the schematic
drawings at the far left. Abbreviations as in Figure 2 of the main
manuscript. The following areas were not examined: OB; OIN;
OC; P. Rectangles indicate areas of magnification shown in the
panels directly below. Scale bars, 100 mm.
Found at: doi:10.1371/journal.pone.0006175.s008 (4.48 MB TIF)
Figure S5 Sensitivity to proteinase K treatment of TSE-
challenged sea bream brain tissues 24 months p.i.. After a short
purification treatment, 0.4 mg brain equivalents from brain
homogenates of either scrapie- (lanes 1, 3, 5 & 7) or BSE-
challenged (lanes 2, 4, 6 & 8) fish, were digested with increasing
proteinase K concentrations (0 mg/ml, lanes 1 & 2; 0.1 mg/ml,
lanes 3 & 4; 1 mg/ml, lanes 5 & 6; 10 mg/ml, lanes 7 & 8) for 1 hr
at 37uC. The samples were analyzed on a 12% SDS-PAGE gel,
then electrotransferred onto a PVDF membrane and probed with
SaurPrP1 polyclonal antibody (1:20000). After incubation with the
appropriate secondary antibody, the immunoblots were finally
developed with the ECL western blotting substrate. Arrowhead,
47.5 kDa.
Found at: doi:10.1371/journal.pone.0006175.s009 (0.27 MB TIF)
Text S1 Statistical analysis of data derived from the scrapie -
challenged group.
Found at: doi:10.1371/journal.pone.0006175.s010 (0.02 MB
DOC)
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